BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3439378)

  • 1. [Ergotism within the scope of the postoperative prevention of thromboembolism].
    Kneist W; Heesen U; Assmann H
    Zentralbl Chir; 1987; 112(22):1426-35. PubMed ID: 3439378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications following preventive treatment of thromboembolism with Dihydergot-heparin].
    Andersen KH; Jeppesen IS
    Ugeskr Laeger; 1989 Aug; 151(33):2072-5. PubMed ID: 2672498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of thromboembolism with heparin and dihydroergotamine in a trauma surgery patient sample--comparison of the effectiveness of different administration forms of dihydroergotamine].
    Schott G; Elsel W; Möckel G; Rothe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(19):973-6. PubMed ID: 1441633
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guides to ergotism, a too little recognized complication of trauma].
    Voigt J; Dortenmann J
    Aktuelle Traumatol; 1983 Feb; 13(1):46-9. PubMed ID: 6132532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
    Lindblad B
    Acta Chir Scand Suppl; 1988; 543():31-42. PubMed ID: 3055779
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W; Peters PE; Irskens U; Schwering H
    Rofo; 1987 Oct; 147(4):446-9. PubMed ID: 2825270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergotism--a severe complication of drug prevention of thromboembolism].
    van den Berg E; Walterbusch G
    Dtsch Med Wochenschr; 1982 May; 107(18):716-8. PubMed ID: 7075489
    [No Abstract]   [Full Text] [Related]  

  • 8. Ergotism leading to threatened limb amputation or to death in two patients given heparin-dihydroergotamine prophylaxis.
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Lancet; 1982 Apr; 1(8278):955-6. PubMed ID: 6122783
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Ashenburg RJ
    J Bone Joint Surg Am; 1990 Jan; 72(1):153. PubMed ID: 2295668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ergotism--an important complication of drug thromboembolism prevention].
    Krupp P; Meyer HE
    Dtsch Med Wochenschr; 1982 Jan; 107(1):36. PubMed ID: 7056149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G
    Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skin necroses and ergotism after preventive administration of heparin-dihydroergotamine].
    Jehn U; Clemm C; Ledderose G
    Dtsch Med Wochenschr; 1983 Jul; 108(30):1148-50. PubMed ID: 6653417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergotism as complication of thromboembolic prophylaxis with heparin-dihydroergotamine.
    Rem JA; Gratzl O; Follath F; Pult I
    Lancet; 1987 Jan; 1(8526):219. PubMed ID: 2880045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ergotism--a serious complication in the chemical prevention of thromboembolism with heparin-DHE].
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Vasa; 1983; 12(1):64-7. PubMed ID: 6837130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of the necessary time for prevention of thromboembolism using heparin/dihydroergotamine during implantation of partial hip joint endoprostheses].
    Maldini B; Matijasević B
    Acta Chir Iugosl; 1989; 36(1):169-78. PubMed ID: 2711804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problem of ergotism in thrombosis prevention with drugs].
    Räber G; Bauermeister U
    Z Arztl Fortbild (Jena); 1983; 77(23):965-8. PubMed ID: 6670300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ergotism--a risk in the prevention of thrombosis?].
    Jahn R
    Zentralbl Chir; 1985; 110(8):482-5. PubMed ID: 4002912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current drug prevention of thromboembolism within the scope of basic inpatient medical management].
    Wegner D; Damme J; Trautmann H
    Z Arztl Fortbild (Jena); 1990; 84(7):317-9. PubMed ID: 2378108
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
    Bounameaux H; Schneider PA; Mossaz A; Suter P; Vasey H
    Vasa; 1987; 16(4):370-2. PubMed ID: 3424957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.